Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) closed the day trading at $2.14 down -24.11% from the previous closing price of $2.82. In other words, the price has decreased by -$24.11 from its previous closing price. On the day, 1.22 million shares were traded. RVPH stock price reached its highest trading level at $2.935 during the session, while it also had its lowest trading level at $2.08.
Ratios:
For a better understanding of RVPH, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.38 and its Current Ratio is at 1.38. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on September 20, 2023, initiated with a Buy rating and assigned the stock a target price of $12.
On June 08, 2023, The Benchmark Company started tracking the stock assigning a Speculative Buy rating and target price of $17.
On January 24, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.H.C. Wainwright initiated its Buy rating on January 24, 2022, with a $10 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVPH now has a Market Capitalization of 59745808 and an Enterprise Value of 55362884.
Stock Price History:
The Beta on a monthly basis for RVPH is 0.03, which has changed by -0.6439394 over the last 52 weeks, in comparison to a change of 0.25590587 over the same period for the S&P500. Over the past 52 weeks, RVPH has reached a high of $9.22, while it has fallen to a 52-week low of $2.67. The 50-Day Moving Average of the stock is -35.65%, while the 200-Day Moving Average is calculated to be -48.66%.
Shares Statistics:
Over the past 3-months, RVPH traded about 253.39K shares per day on average, while over the past 10 days, RVPH traded about 135770 shares per day. A total of 27.92M shares are outstanding, with a floating share count of 22.97M. Insiders hold about 17.71% of the company’s shares, while institutions hold 18.19% stake in the company. Shares short for RVPH as of 1713139200 were 1234859 with a Short Ratio of 4.87, compared to 1710460800 on 650652. Therefore, it implies a Short% of Shares Outstanding of 1234859 and a Short% of Float of 6.6300004999999995.
Earnings Estimates
Investors are keenly observing as 3.0 analysts analyze and rate the current performance of Reviva Pharmaceuticals Holdings Inc. (RVPH) in the stock market.On average, analysts expect EPS of -$0.38 for the current quarter, with a high estimate of -$0.28 and a low estimate of -$0.46, while EPS last year was -$0.3. The consensus estimate for the next quarter is -$0.36, with high estimates of -$0.22 and low estimates of -$0.48.
Analysts are recommending an EPS of between -$0.82 and -$1.87 for the fiscal current year, implying an average EPS of -$1.29. EPS for the following year is -$1.31, with 4.0 analysts recommending between -$0.76 and -$2.11.
